These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11028839)

  • 1. The challenge of fibromyalgia: new approaches.
    Müller W; Pongratz D; Bärlin E; Eich W; Färber L; Haus U; Lautenschläger J; Mense S; Neeck G; Offenbächer M; Späth M; Stratz T; Tolk J; Welzel D; Wiech K; Wohlgemuth M
    Scand J Rheumatol Suppl; 2000; 113():86. PubMed ID: 11028839
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pilot study with 5-HT3 antagonists. Good outcome in fibromyalgia pain].
    Stratz T; Müller W
    MMW Fortschr Med; 2002 Mar; 144(11):49. PubMed ID: 12066514
    [No Abstract]   [Full Text] [Related]  

  • 3. Short-term treatment of primary fibromyalgia with the 5-HT3-receptor antagonist tropisetron. Results of a randomized, double-blind, placebo-controlled multicenter trial in 418 patients.
    Färber L; Stratz TH; Brückle W; Späth M; Pongratz D; Lautenschläger J; Kötter I; Zöller B; Peter HH; Neeck G; Welzel D; Müller W;
    Int J Clin Pharmacol Res; 2001; 21(1):1-13. PubMed ID: 11708570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia.
    Späth M; Stratz T; Neeck G; Kötter I; Hammel B; Amberger CC; Haus U; Färber L; Pongratz D; Müller W
    Scand J Rheumatol; 2004; 33(4):267-70. PubMed ID: 15370724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [5-HT3-receptor-antagonists in therapy of rheumatic diseases].
    Müller W; Stratz T
    Z Rheumatol; 2003 Feb; 62(1):39-41. PubMed ID: 12624802
    [No Abstract]   [Full Text] [Related]  

  • 6. 5-HT3 receptor antagonists: a new therapeutic approach in rheumatology? Proceedings of a symposium. Frankfurt, Germany, February 12-13, 2004.
    Scand J Rheumatol Suppl; 2004; 119():1-80. PubMed ID: 15584135
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibromyalgia treatment with intravenous tropisetron administration.
    Stratz T; Färber L; Varga B; Baumgartner C; Haus U; Müller W
    Drugs Exp Clin Res; 2001; 27(3):113-8. PubMed ID: 11447769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do cytochrome enzymes influence the therapeutic effect of tropisetron in fibromyalgia?
    Stratz T; Kees F; Müller W
    Drugs Exp Clin Res; 2003; 29(2):91-4. PubMed ID: 12951840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do predictors exist for the therapeutic effect of 5-HT3 receptor antagonists in fibromyalgia?
    Stratz T; Müller W
    Scand J Rheumatol Suppl; 2000; 113():63-5. PubMed ID: 11028835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy for irritable bowel syndrome.
    Lacy BE
    N Engl J Med; 2004 Mar; 350(12):1261-3; author reply 1261-3. PubMed ID: 15031865
    [No Abstract]   [Full Text] [Related]  

  • 11. Update on irritable bowel syndrome.
    Bergmann KA
    Postgrad Med J; 2003 Dec; 79(938):715. PubMed ID: 14707260
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fibromyalgia: a challenge for neuroscience].
    Leza JC
    Rev Neurol; 2003 Jun 16-30; 36(12):1165-75. PubMed ID: 12833238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibromyalgia: a complex syndrome requiring a multidisciplinary approach.
    Spaeth M; Briley M
    Hum Psychopharmacol; 2009 Jun; 24 Suppl 1():S3-10. PubMed ID: 19479907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibromyalgia: combining pharmacological and nonpharmacological approaches to treating the person, not just the pain.
    Turk DC; Vierck CJ; Scarbrough E; Crofford LJ; Rudin NJ
    J Pain; 2008 Feb; 9(2):99-104. PubMed ID: 17936075
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fibromyalgia: understanding the disease and its social implications].
    Colladdo A; de Santos P
    Rev Esp Anestesiol Reanim; 2006 Jan; 53(1):1-3. PubMed ID: 16475632
    [No Abstract]   [Full Text] [Related]  

  • 16. [Is fibromyalgia a neurological disease?].
    Arias M
    Neurologia; 2008 Nov; 23(9):593-601. PubMed ID: 18925441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tegaserod and other serotonergic agents: what is the evidence?
    Chey WD
    Rev Gastroenterol Disord; 2003; 3 Suppl 2():S35-40. PubMed ID: 12776001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibromyalgia 20 years later: what have we really accomplished?
    Carette S
    J Rheumatol; 1995 Apr; 22(4):590-4. PubMed ID: 7791148
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fibromyalgia--effect of exercise].
    Kurtze N
    Tidsskr Nor Laegeforen; 2004 Oct; 124(19):2475-8. PubMed ID: 15477883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of disease: pain in fibromyalgia syndrome.
    Staud R; Rodriguez ME
    Nat Clin Pract Rheumatol; 2006 Feb; 2(2):90-8. PubMed ID: 16932662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.